|
NZ592039A
(en)
|
2003-08-27 |
2013-03-28 |
Ophthotech Corp |
Combination therapy for the treatment of ocular neovascular disorders
|
|
JP5529851B2
(ja)
|
2008-04-18 |
2014-06-25 |
リアタ ファーマシューティカルズ インコーポレイテッド |
抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
EA201390172A1
(ru)
*
|
2011-04-26 |
2013-09-30 |
ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" |
Способ получения пэгилированных олигонуклеотидов
|
|
KR20140048218A
(ko)
|
2011-06-28 |
2014-04-23 |
바이엘 헬스케어 엘엘씨 |
레고라페닙을 함유하는 국소 안과용 약학 조성물
|
|
CN103764118A
(zh)
|
2011-06-28 |
2014-04-30 |
拜尔健康护理有限责任公司 |
含有索拉非尼的局部眼用药用组合物
|
|
US20130142796A1
(en)
*
|
2011-12-05 |
2013-06-06 |
Subhransu Ray |
Treatment for angiogenic disorders
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
TWI588560B
(zh)
|
2012-04-05 |
2017-06-21 |
布萊恩荷登視覺協會 |
用於屈光不正之鏡片、裝置、方法及系統
|
|
TWI623548B
(zh)
|
2012-04-27 |
2018-05-11 |
瑞塔醫藥有限責任公司 |
齊墩果酸（ｂａｒｄｏｘｏｌｏｎｅ ｍｅｔｈｙｌ）之２，２-二氟基丙醯胺衍生物、多晶型及其使用方法
|
|
AU2013267310A1
(en)
*
|
2012-06-01 |
2014-12-11 |
Ophthotech Corporation |
Compositions comprising an anti-PDGF aptamer and a VEGF antagonist
|
|
US9156897B2
(en)
*
|
2012-06-08 |
2015-10-13 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
WO2013188283A1
(en)
|
2012-06-12 |
2013-12-19 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing sunitinib
|
|
HK1204564A1
(en)
*
|
2012-06-25 |
2015-11-27 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing axitinib
|
|
DE202013000688U1
(de)
*
|
2012-07-03 |
2013-03-05 |
Novartis Ag |
Glas-Spritze
|
|
AU2013100070B4
(en)
*
|
2012-07-03 |
2013-04-04 |
Novartis Ag |
Use of device
|
|
US9201250B2
(en)
|
2012-10-17 |
2015-12-01 |
Brien Holden Vision Institute |
Lenses, devices, methods and systems for refractive error
|
|
SG11201502115RA
(en)
|
2012-10-17 |
2015-05-28 |
Holden Brien Vision Inst |
Lenses, devices, methods and systems for refractive error
|
|
US9681805B2
(en)
*
|
2012-11-05 |
2017-06-20 |
Babak Kamkar |
Afferent pupil tester
|
|
UY35183A
(es)
|
2012-12-21 |
2014-07-31 |
Bayer Healthcare Llc |
Composición farmacéutica oftalmológica tópica que contiene regorafenib
|
|
JO3405B1
(ar)
|
2013-01-09 |
2019-10-20 |
Regeneron Pharma |
الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
|
|
RS60026B1
(sr)
|
2013-02-18 |
2020-04-30 |
Vegenics Pty Ltd |
Molekuli koji vezuju ligande i njihove upotrebe
|
|
US10590161B2
(en)
|
2013-03-15 |
2020-03-17 |
Modernatx, Inc. |
Ion exchange purification of mRNA
|
|
WO2014152031A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Ribonucleic acid purification
|
|
WO2014152027A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Manufacturing methods for production of rna transcripts
|
|
EP2971165A4
(en)
|
2013-03-15 |
2016-11-23 |
Moderna Therapeutics Inc |
DISSOLUTION OF DNA FRAGMENTS IN MRNA MANUFACTURING METHODS
|
|
AR096046A1
(es)
|
2013-04-24 |
2015-12-02 |
Abbvie Inc |
Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso
|
|
EP2994758B1
(en)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarkers for age-related macular degeneration (amd)
|
|
US20160137717A1
(en)
*
|
2013-06-20 |
2016-05-19 |
Gabriela Burian |
Use of a vegf antagonist in treating choroidal neovascularisation
|
|
WO2014203181A1
(en)
*
|
2013-06-20 |
2014-12-24 |
Novartis Ag |
Treatment of polypoidal choroidal vasculopathy
|
|
EP3019526A1
(en)
*
|
2013-07-11 |
2016-05-18 |
Novartis AG |
Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients
|
|
CA2917348A1
(en)
|
2013-07-11 |
2015-01-15 |
Moderna Therapeutics, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
|
RU2676303C2
(ru)
*
|
2013-07-11 |
2018-12-27 |
Новартис Аг |
Использование антагониста vegf для лечения ретролентальной фиброплазии
|
|
DK4374873T3
(da)
|
2013-07-12 |
2025-11-03 |
Astellas Us Llc |
Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande
|
|
WO2015035342A2
(en)
|
2013-09-08 |
2015-03-12 |
Oligasis Llc |
Factor viii zwitterionic polymer conjugates
|
|
US20170250927A1
(en)
*
|
2013-12-23 |
2017-08-31 |
Dali Systems Co. Ltd. |
Virtual radio access network using software-defined network of remotes and digital multiplexing switches
|
|
US20170175129A1
(en)
*
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
WO2015196128A2
(en)
*
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
|
CA2957618A1
(en)
|
2014-08-04 |
2016-02-11 |
MiRagen Therapeutics, Inc. |
Inhibitors of myh7b and uses thereof
|
|
RU2017105844A
(ru)
*
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
US20160038589A1
(en)
*
|
2014-08-11 |
2016-02-11 |
Ophthotech Corporation |
Methods for treating or preventing ophthalmological conditions
|
|
KR20210013299A
(ko)
|
2014-10-17 |
2021-02-03 |
코디악 사이언시스 인코포레이티드 |
부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
|
|
HUE055500T2
(hu)
*
|
2015-03-09 |
2021-11-29 |
Sinai Health Sys |
Eszközök és módszerek a sejtdivíciós loci használatára a sejtek szaporodásának szabályozására
|
|
US11578110B2
(en)
*
|
2015-08-25 |
2023-02-14 |
Histide Ag |
Compounds for inducing tissue formation and uses thereof
|
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
|
EP3350333B2
(en)
|
2015-09-17 |
2025-08-06 |
ModernaTX, Inc. |
Polynucleotides containing a stabilizing tail region
|
|
WO2017065559A1
(ko)
*
|
2015-10-15 |
2017-04-20 |
(주)알테오젠 |
Igg fc 도메인을 가지는 융합 단백질의 생산방법
|
|
KR101936049B1
(ko)
|
2015-10-15 |
2019-01-08 |
(주)알테오젠 |
IgG Fc 도메인을 가지는 융합 단백질의 생산방법
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
KR101795650B1
(ko)
|
2016-05-12 |
2017-11-09 |
인제대학교 산학협력단 |
아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
|
|
KR101795653B1
(ko)
|
2016-05-19 |
2017-11-09 |
인제대학교 산학협력단 |
콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
|
|
WO2017223176A1
(en)
|
2016-06-24 |
2017-12-28 |
Modernatx, Inc. |
Methods and apparatus for filtration
|
|
CA3040179A1
(en)
|
2016-10-19 |
2018-04-26 |
Adverum Biotechnologies, Inc. |
Modified aav capsids and uses thereof
|
|
CN106778685A
(zh)
*
|
2017-01-12 |
2017-05-31 |
司马大大（北京）智能系统有限公司 |
心电图图像识别方法、装置及服务终端
|
|
CN109428697B
(zh)
|
2017-08-25 |
2021-12-28 |
华为技术有限公司 |
数据传输方法、网络设备及终端设备
|
|
CN108256457B
(zh)
*
|
2018-01-09 |
2021-06-04 |
东北大学 |
一种基于深度神经网络的心冲击信号深瓶颈特征提取方法
|
|
EP3758737A4
(en)
|
2018-03-02 |
2022-10-12 |
Kodiak Sciences Inc. |
IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
|
|
CN108920529A
(zh)
*
|
2018-06-07 |
2018-11-30 |
北京金山安全软件有限公司 |
一种数据提取方法、装置及电子设备
|
|
JP2022535717A
(ja)
|
2019-05-24 |
2022-08-10 |
エンピリコ インク． |
アンジオポエチン様７（ａｎｇｐｔｌ７）関連疾患の処置
|
|
EP3886946A1
(en)
|
2019-06-05 |
2021-10-06 |
Regeneron Pharmaceuticals, Inc. |
Devices and methods for precision dose delivery
|
|
CN110257383B
(zh)
*
|
2019-06-24 |
2023-05-26 |
湖北师范大学 |
特异性识别邻苯二甲酸二(2-乙基）己酯的核酸适配体及其筛选方法与应用
|
|
CN110522902B
(zh)
*
|
2019-09-25 |
2022-10-11 |
南京农业大学 |
一种用于建立慢性肾病模型的组合物及其应用
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
FI4065585T3
(fi)
|
2019-11-25 |
2025-09-26 |
Alkermes Inc |
Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä
|
|
CN115397850A
(zh)
|
2020-03-30 |
2022-11-25 |
豪夫迈·罗氏有限公司 |
与vegf和pdgf-b结合的抗体及其使用方法
|
|
US11760747B2
(en)
|
2020-12-21 |
2023-09-19 |
Alkermes, Inc. |
Substituted piperidino compounds and related methods of treatment
|
|
KR102338093B1
(ko)
*
|
2021-01-14 |
2021-12-10 |
국민대학교 산학협력단 |
(7S)-(+)-시클로펜틸 카바믹산, 8,8-디메틸-2-옥소-6,7-디히드로-2H,8H-피라노[3,2-g]크로멘-7-일-에스테르를 유효성분으로 포함하는 안질환의 예방, 개선 또는 치료용 조성물
|
|
CN112675158A
(zh)
*
|
2021-01-26 |
2021-04-20 |
苏州市立医院 |
紫草醌在制备脉络膜新生血管治疗药物中的作用
|
|
MX2023011268A
(es)
|
2021-03-24 |
2023-12-14 |
Alkermes Inc |
Anticuerpos upar y proteínas de fusión con estos.
|
|
CN112852749A
(zh)
*
|
2021-03-27 |
2021-05-28 |
哈尔滨元亨生物药业有限公司 |
高效分泌犬细小病毒单克隆抗体杂交瘤细胞株c68及利用生物反应器对其进行生产的方法
|
|
US20240252679A1
(en)
|
2021-05-28 |
2024-08-01 |
Shanghai Regenelead Therapies Co., Ltd. |
Recombinant adeno-associated virus having variant capsid, and application thereof
|
|
CN113466782B
(zh)
*
|
2021-06-08 |
2022-09-13 |
同济大学 |
一种基于深度学习(dl)的互耦校正doa估计方法
|
|
US20250197859A1
(en)
*
|
2022-03-28 |
2025-06-19 |
Empirico Inc. |
Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases
|
|
AU2023245603A1
(en)
*
|
2022-03-28 |
2024-11-07 |
Empirico Inc. |
Modified oligonucleotides
|
|
WO2023239415A1
(en)
*
|
2022-06-08 |
2023-12-14 |
Angrow Company Limited |
Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject
|
|
USD1120314S1
(en)
|
2022-11-30 |
2026-03-24 |
Regeneron Pharmaceuticals, Inc. |
Dose delivery device
|
|
CN118766879B
(zh)
*
|
2024-07-12 |
2025-10-10 |
华中科技大学 |
蒽醌类化合物aloesaponarin II在制备CVB3病毒抑制剂中的应用
|
|
CN118898773B
(zh)
*
|
2024-10-09 |
2024-12-17 |
江西师范大学 |
基于多尺度特征融合的医学图像分割方法和设备
|
|
CN121177569B
(zh)
*
|
2025-11-21 |
2026-02-24 |
重庆医科大学附属口腔医院(重庆市口腔医院) |
一种感染性骨缺损仿生修复水凝胶支架及其制备方法和应用
|